Tue, Oct 10, 2017, 8:00 am to 9:00 am
Upon completion of this session, the participant shall be able to:
- Review the incidence, prevention and clinical diagnosis of Alzheimer’s disease.
- Describe the pathophysiology of Alzheimer’s disease with the emerging importance of Tau mechanisms.
- Discuss the latest updates regarding the Alzheimer’s disease pipeline, approval and the goal of getting a disease prevention drug by 2025.
- Discuss the Global Alzheimer Program (GAP) Foundation.
You must have a pass to attend Grand Rounds. Please email hpa@ to find out how to get one. Thank you!
Schreyer Education Building @ UMCPP, Conference Rooms C, D & E